Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Journal of Receptor and Signal Transduction Research|February 25, 2016
Structural insights into the Aedes aegypti aquaporins and aquaglyceroporins - an in silico studySandhya Sreedharan, Gugan Kothandan, Kavitha SankaranarayananBiochimica Et Biophysica Acta. Molecular Basis of Disease|July 20, 2020
Berberine and Emodin abrogates breast cancer growth and facilitates apoptosis through inactivation of SIK3-induced mTOR and Akt signaling pathwayLavanya Ponnusamy, Gugan Kothandan, Ravi ManoharanIn Silico Pharmacology|September 23, 2024
Anticipatory in silico vaccine designing based on specific antigenic epitopes from Streptococcus mutans against diabetic pathogenesisGopinath Murugan, Gugan Kothandan, Rajashree PadmanabanPlos One|April 6, 2012
Structural insights from binding poses of CCR2 and CCR5 with clinically important antagonists: a combined in silico studyGugan Kothandan, Changdev G Gadhe, Seung Joo ChoChemical Biology & Drug Design|March 7, 2013
Theoretical characterization of galanin receptor type 3 (Gal3 ) and its interaction with agonist (GALANIN) and antagonists (SNAP 37889 and SNAP 398299): an in silico analysisGugan Kothandan, Changdev G Gadhe, Seung J ChoAnti-Cancer Agents in Medicinal Chemistry|June 26, 2013
In silico study of desmosdumotin as an anticancer agent: homology modeling, docking and molecular dynamics simulation approachChangdev G Gadhe, Gugan Kothandan, Seung Joo ChoJournal of Biomolecular Structure & Dynamics|November 17, 2012
Computational modeling of human coreceptor CCR5 antagonist as a HIV-1 entry inhibitor: using an integrated homology modeling, docking, and membrane molecular dynamics simulation analysis approachChangdev G Gadhe, Gugan Kothandan, Seung Joo ChoArchives of Pharmacal Research|January 18, 2013
Binding site exploration of CCR5 using in silico methodologies: a 3D-QSAR approachChangdev G Gadhe, Gugan Kothandan, Seung Joo ChoMolecular Biosystems|December 3, 2013
Molecular insights on TNKS1/TNKS2 and inhibitor-IWR1 interactionsPalani Kirubakaran, Gugan Kothandan, Seung J Cho, et al.In Silico Pharmacology|October 6, 2025
In silico design and assessment of a multiepitope and multiantigen potential vaccine candidate against Leishmania donovaniSatabdi Saha, Sahina Laskar, Seshan Gunalan, et al.Pageof 4